« Innovation Update | Main | Sixteen New Biotech Drug Approvals in 2009 »
Bruce Carlson (Kalorama) writes that the world cell culture market reached $1.87 billion in sales in 2008 and is expected to grow to $3.4 billion by 2013, a CAGR of 12%. You can read more in the Jan 15th issue of GEN.
As an industry participant, I see Mr. Carlson's estimates as being a tad optimistic.
Posted by Bruce Lehr Jan 17, 2010
| | |
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0120a7e57131970b
Listed below are links to weblogs that reference Cell Culture Market:
You can follow this conversation by subscribing to the comment feed for this post.
The comments to this entry are closed.
I would agree that alternatives to cell culture will emerge and may be in early stages of doing so, but I think "reports of cell culture's death are greatly exaggerated" to paraphrase a fellow Missourian. My comment had more to do with the market CAGR in excess of 12% as cited by Kalorama was being too aggressive.
Posted by: Bruce Lehr | 01/20/2010 at 03:13 PM
I would agree that it is a little optimistic. Let's face it; cell culture production is inconsistent and inefficient. Technically, good alternatives (i.e. pharming) for biologics production are available (Disruptive innovation). It is just matter of time before the agency (FDA) catches up, and start approving the better methods for biologics production. Then, the cell culture market will be another victim of creative destructions (see sera)...
Posted by: Fai | 01/20/2010 at 02:19 PM